Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2007-09-13
2010-12-14
Navarro, Mark (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S191100, C530S350000
Reexamination Certificate
active
07850972
ABSTRACT:
Cloning and expression of genes encodingC. parvumantigenic polypeptides are described as are antibodies that recognize epitopes on these polypeptides. The antigenic polypeptides and antibodies thereto can be used in therapeutic compositions for the prevention and treatment ofC. parvuminfections, as well as in diagnostic methods for determining the presence ofC. parvuminfections.
REFERENCES:
patent: 5591434 (1997-01-01), Jenkins et al.
patent: 5643772 (1997-07-01), Petersen et al.
patent: 5773245 (1998-06-01), Wittrup et al.
patent: 6323020 (2001-11-01), Perryman et al.
patent: WO 98/07320 (1998-02-01), None
Arrowood et al., “Effect of Immune Colostrum and Orally Adminstered Antisporozoite Monoclonal Antibodies on the Outcome ofCryptosporidium parvumInfections in neonatal Mice,”Infect. Immun.57(8):2283-2288 (1989).
Bjorneby et al., “Monoclonal Antibodiy Immunotherapy in Nude Mice Persistently Infected withCryptosporidium parvum,” Infect. Immun.59(3):1172-1176 (1993).
Campbell et al., “Demonstration of Serum Antibodies toCryptospridiumsp. In Normal and Immunodeficient Humans with Confirmed Infections,”Journal of Clinical Microbiology18(1):165-169 (1983).
Doyle et al., “Anti-Cryptosporidium parvumAntibodies Inhibit Infectivity In Vitro and In Vivo,”Infect. Immun.61:4079-4084 (1993).
Jenkins et al., “Cloning and Expression of a cDNA Encoding Epitopes Shared by 15-and 60-Kilodalton Proteins ofCryptosporidium parvumSporozoites,”Infection and Immunity61(6):2377-2382 (1993).
Jenkins et al., “Cloning and Expression of cDanA Encoding an AntigenicCryptosporidium parvumProtein,”Molecular and Biochemical Parasitology71:149-152 (1995).
Lillehoj et al., “CD8+T Cell-Coccidia Interactions,”Parsitology Today10:10-16 (1994).
McDonald et al., “Localization of Parsite Antigens inCryptosporidium parvum-Infected Epithelial Cells Using Monoclonal Antibodies,”Parasitology110:259-268 (1995).
Mead, J.R. et al., “Antigens ofCryptosporidiumSporozoites Recognized by Immune Sera of Infected Animals and Humans,”Journal of Parasitology74(1):135-143 (1988).
Nina et al., “Analysis of Oocyst Wall and Sporozoite Antigens from ThreeCryptosporidiumSpecies,”Infection and Immunity60(4):1509-1513 (1992).
Nord et al., “Treatment of AID Associated Cryptosporidiosis With Hyperimmune Colostrum From Cows Vaccinated withCryptosporidium,” Fifth International Conference on Aids, Montreal, Quebec, May 1989.
Ortega-Mora et al., “Cross-Reactivity of Polyclonal Serum Antibodies Generated AgainstCryptosporidium parvumOocyst,”Infection and Immunity60(8):3442-3445 (1992).
Peeters et al., “Cryptosporidium parvumin Calves: Kinetics and Immunoblot Analysis of Specific Serum and Local Antibody Responses (Immunoglobulin A [IgA], IgG, and IgM) After Natural and Experimental Infections,”Infection and Immunity60(6):2309-2316 (1992).
Peterson et al., “Identification and Initial characterization of FiveCryptosporidium parvumSporozoite Antigen Genes,”Infection and Immunity60(6):2343-2348 (1992).
Ranucci et al., “Characterization and Immunolocalization of aCryptosporidiumProtein Containing Repeated Amino Acid Motifs,”Infection and Immunity61(6):2347-2356 (1993).
Reperant, Jean-Michel et al., “Major Antigens ofCryptosporidium parvumRecognized by Serum Antibodies from Different Infected Animal Species and Man,”Veterinary Parasitology55(1-2):1-13 (1994).
Strong, W.B. et al., “Cloning and Sequence Analysis of a Highly PolymorphicCryptosporidium parvumGene Encoding a 60-Kilodalton Glycoprotein and Characterization of its 15-and 45-Kilodalton Ziote Surface Antigen Products,”Infection and Immunity, American Society For Microbiology, Washington, U.S. 68(7):4117-4134 (2000).
Tzipori et al., “Remission of Diarhoea due to cryptosporidiosis in an Immunodeficient Child Treated with Hyperimmune Bove Colostrum,”British Medical Journal293:1276-1277 (1986).
Ungar et al., “Cessation ofCryptosporidium-Associated Diarrehea in an Acquired Immunodeficiency Syndrome Patient After Treatment With Hyperimmune Bovine Colostrum,”Gastroenterology98:486-489 (1990).
Whitmire et al., “Characterization of Bovine Cellular and Serum Antibody Responses during Infection byCryptosporidium parvum,” Infection and Immunity59(3):990-995 (1991).
Accession No. AF178459 “Neutralising Antigen 2 ofCryptosporidium parvumRecognised by Human Immune Sera,” XP002205089, Sep. 5, 2000.
Accession No. AF178460 “Neutralising Antigen 1 ofC. parvumRecognised by Human Immune Sera,” XP0021694444, Sep. 5, 2000.
Accession No. AQ411949 “CpG 0925 A C[OPWAgDMA1C. parvumGenomics, Genomic Survey Sequence,” XP002205088, Mar. 25, 1999.
Accession No. AQ988925 “Cryptosporidium parvumGenomic Clone 25A1A08NE,” XP002194443, Feb. 3, 2000.
Riggs et al., “Neutralization-Sensitive Epitopes Are Exposed on the Surface of InfectiousCryptosporidium parvumSporozoites,”The Journal of Immunolology1989 143(4):1340-1345.
Navarro Mark
Robins & Pasternak LLP
University of Manitoba
LandOfFree
Cryptosporidium parvum antigens, antibodies thereto and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cryptosporidium parvum antigens, antibodies thereto and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cryptosporidium parvum antigens, antibodies thereto and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4205536